Improved use of antitumoral compound in cancer therapy
Details for Australian Patent Application No. 2002343548 (hide)
International Classifications
Event Publications
27 February 2003 Complete Application Filed
Priority application(s): 60/348,414 19.10.01 US
24 July 2003 Application Open to Public Inspection
Published as AU-B-2002343548
20 May 2004 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from Pharmamar S.A. to Pharma Mar, S.A.
8 November 2007 Application Accepted
Published as AU-B-2002343548
17 January 2008 Corrigenda
Applications Accepted - Name Index Under the name Pharma Mar, S.A., Application NO. 2002343548, under INID (72), correct the co-inventor name to read Lopez Lazaro, Luis
6 March 2008 Standard Patent Sealed
20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser